This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
Mistake 1: Shaking the vial This one deserves its own section because it happens constantly
Explore B12 Shots & B12 Injections: The Good, Bad and Alternative, featuring insights from the esteemed Baby Ken
To understand where this fits, learn how supervised peptide therapy at Perfect B in Doral is structured and how it supports safe, monitored use of peptides
Patients interested in BPC-157 should speak with a licensed medical provider and use only appropriate pharmacy channels when clinically indicated